Efficacy of eribulin in breast cancer: a short report on the emerging new data

Eslamian, G., Wilson, C. and Young, R.J. (2017) Efficacy of eribulin in breast cancer: a short report on the emerging new data. ONCOTARGETS AND THERAPY, 10. pp. 773-779.

Abstract

Metadata

Authors/Creators:
  • Eslamian, G.
  • Wilson, C.
  • Young, R.J.
Copyright, Publisher and Additional Information: This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License (https://creativecommons.org/licenses/by-nc/3.0/) By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Keywords: eribulin; microtubule-targeting agents; breast cancer
Dates:
  • Published: 13 February 2017
  • Accepted: 14 January 2017
Institution: The University of Sheffield
Depositing User: Symplectic Sheffield
Date Deposited: 27 Mar 2017 08:41
Last Modified: 27 Mar 2017 08:41
Published Version: https://doi.org/10.2147/OTT.S102638
Status: Published
Publisher: Dove Medical Press
Identification Number: https://doi.org/10.2147/OTT.S102638
Related URLs:

Share / Export

Statistics